1,4-Butanediol

1,4-Butanediol (1,4-BD) is a clear, odorless industrial solvent that functions as a prodrug of gamma-hydroxybutyrate (GHB) in the human body. Upon ingestion, alcohol dehydrogenase and aldehyde dehydrogenase enzymes convert 1,4-BD sequentially to gamma-butyrolactone (GBL) and then to GHB, producing effects pharmacologically indistinguishable from those of GHB itself — sedation, euphoria, anxiolysis, and dose-dependent amnesia. The delay between ingestion and onset varies considerably depending on whether the stomach is empty or full, creating significant risk of redosing before the first dose has fully converted.

1,4-BD is widely available as an industrial cleaning agent and solvent, and has historically occupied legal gray areas precisely because it is not itself a controlled substance in many jurisdictions despite functioning identically to controlled GHB once ingested. This regulatory gap led to widespread recreational use in the early 2000s, often sold openly at gyms and health food stores under names like "Revitalize Plus" or "Thunder Nectar." Its availability and inexpensive cost have made it attractive to those seeking GHB-like effects, but its narrow therapeutic window — the difference between a recreational dose and a dangerous one — mirrors that of GHB and is compounded by the pharmacokinetic uncertainty of prodrug conversion.

Community experience consistently flags 1,4-BD as one of the more dangerous GABAergic depressants. The prodrug conversion delay means users may incorrectly assume a dose has failed and redose, resulting in profound, combined overdose when both doses convert simultaneously. Combined with alcohol, which competes for the same enzymatic pathway and simultaneously potentiates CNS depression, even modest amounts of 1,4-BD can produce respiratory depression, unconsciousness, and death. Experience reports in the database reflect both therapeutic use for anxiety and a sobering trajectory toward dependence and increasingly narrow control over dosing.